[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:focal-segmental-glomerulosclerosis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":145,"states":146},"Focal Segmental Glomerulosclerosis",22,21,[8,16,22,29,36,42,48,54,60,66,72,78,83,89,95,101,107,113,119,125,131,137],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06500702","A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease",[12],"Phase 2","RECRUITING","2026-08-26T02:19:17.380174Z","2026-07-24T01:27:14.871331Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07268638","A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)",[12],"2026-08-26T02:17:09.131534Z","2026-07-19T19:36:05.068499Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT07220083","A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)",[26],"Phase 3","2026-08-26T02:18:39.640967Z","2026-07-19T19:36:05.066165Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06090227","AMPK-activation by Metformin in FSGS: AMP-FSGS",[33],"Phase 1\u002FPhase 2","2026-08-26T02:16:20.336282Z","2026-05-05T02:43:29.710724Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT04065438","Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System",[],"2026-08-26T02:18:31.164304Z","2026-05-05T02:43:28.176716Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06664814","An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis",[12],"2026-08-26T02:16:56.877406Z","2026-05-05T02:43:27.447113Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT02235857","Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children",[],"2026-08-26T02:19:29.119921Z","2026-05-05T02:43:27.112376Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT05183646","A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB",[26],"2026-08-26T02:17:59.904383Z","2026-05-05T02:35:31.903543Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT05588063","taVNS for FRNS in Children",[],"2026-08-26T02:15:47.754948Z","2026-05-05T02:43:28.534280Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT05583942","A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)",[],"2026-08-26T02:16:12.203827Z","2026-05-05T02:35:31.917205Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06983028","Atacicept in Multiple Glomerular Diseases",[12],"2026-08-26T02:17:42.501124Z","2026-07-05T05:32:16.725563Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":64,"content_modified":82},"NCT05508009","Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor",[33],"2026-05-05T02:43:28.845160Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT06466135","Study of WAL0921 in Patients With Glomerular Kidney Diseases",[12],"2026-08-26T02:17:48.768272Z","2026-05-05T02:43:28.312447Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT07355296","PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease",[12],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:27.860054Z",{"nct_id":96,"title":97,"phases":98,"status":13,"updated_at":99,"content_modified":100},"NCT05003986","Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases",[12],"2026-08-26T02:17:00.709807Z","2026-04-29T02:57:57.147910Z",{"nct_id":102,"title":103,"phases":104,"status":13,"updated_at":105,"content_modified":106},"NCT05650619","Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease",[],"2026-08-26T02:16:41.943926Z","2026-05-13T02:55:06.366984Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":111,"content_modified":112},"NCT01094327","Proteinuria in Pre and Post Transplant",[],"2026-08-26T02:17:40.683658Z","2026-05-13T02:55:06.066948Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT01209000","Nephrotic Syndrome Study Network",[],"2026-08-26T02:15:52.238965Z","2026-05-13T02:55:06.070702Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":123,"content_modified":124},"NCT05505500","Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.",[],"2026-08-26T02:17:39.857430Z","2026-05-13T02:55:06.351871Z",{"nct_id":126,"title":127,"phases":128,"status":13,"updated_at":129,"content_modified":130},"NCT04571658","NEPTUNE Match Study",[],"2026-08-26T02:17:27.435233Z","2026-05-05T02:43:27.293689Z",{"nct_id":132,"title":133,"phases":134,"status":13,"updated_at":135,"content_modified":136},"NCT07516964","SLIT ABS: Study on Patients With Autoimmune Podocytopathy",[],"2026-08-26T02:18:11.042248Z","2026-05-05T02:35:31.759914Z",{"nct_id":138,"title":139,"phases":140,"status":142,"updated_at":143,"content_modified":144},"NCT07219121","Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis",[141],"Phase 4","ACTIVE_NOT_RECRUITING","2026-08-03T02:02:26.137944Z","2026-05-05T02:43:29.153210Z",[],[147,151,155,158,162,166,169,172,176,180,184,188,191,194,197,201,204,208,212,215,218,221],{"state":148,"count":149,"slug":150},"New York",13,"new-york",{"state":152,"count":153,"slug":154},"California",12,"california",{"state":156,"count":153,"slug":157},"Michigan","michigan",{"state":159,"count":160,"slug":161},"North Carolina",11,"north-carolina",{"state":163,"count":164,"slug":165},"Florida",10,"florida",{"state":167,"count":164,"slug":168},"Ohio","ohio",{"state":170,"count":164,"slug":171},"Pennsylvania","pennsylvania",{"state":173,"count":174,"slug":175},"Texas",9,"texas",{"state":177,"count":178,"slug":179},"Illinois",8,"illinois",{"state":181,"count":182,"slug":183},"Georgia",7,"georgia",{"state":185,"count":186,"slug":187},"Colorado",6,"colorado",{"state":189,"count":186,"slug":190},"Maryland","maryland",{"state":192,"count":186,"slug":193},"Minnesota","minnesota",{"state":195,"count":186,"slug":196},"South Carolina","south-carolina",{"state":198,"count":199,"slug":200},"Alabama",5,"alabama",{"state":202,"count":199,"slug":203},"Missouri","missouri",{"state":205,"count":206,"slug":207},"Washington",4,"washington",{"state":209,"count":210,"slug":211},"Delaware",3,"delaware",{"state":213,"count":210,"slug":214},"Kansas","kansas",{"state":216,"count":210,"slug":217},"Massachusetts","massachusetts",{"state":219,"count":210,"slug":220},"Tennessee","tennessee",{"state":222,"count":210,"slug":223},"Virginia","virginia"]